Overweight/obese women with polycystic ovary syndrome (PCOS) who used oral contraceptives experienced both an improved HDL-C function and a poorer LDL-C profile, according to a secondary analysis of a randomized controlled trial involving 87 women. Adding a lifestyle program improved the negative impact.
Participants—all of whom had PCOS and were overweight/obese—were assigned to receive 1) oral contraceptives; 2) lifestyle modification; or 3) both for 16 weeks. Investigators looked at impact on cholesterol levels. Among the results:
- HDL-C efflux capacity increased significantly in the oral contraceptive group only.
- After adjusting for HDL-C and triglycerides, efflux change was significant in the combination group as well.
- Change in HDL-C efflux correlated inversely with change in testosterone levels.
- Oral contraceptives alone induced an atherogenic LDL-C profile; the other 2 groups did not experience such.
The authors concluded that combining oral contraceptives with lifestyle changes might be beneficial in overweight/obese women with PCOS.
Dokras A, Playford M, Kris-Etherton P, et al. Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome. [Published online ahead of print March 9, 2017]. Clin Endocrinol. doi:10.1111/cen.13310.
This Week's Must Reads
Glucose Predicts Mortality in Surgical Patients , Diabetes Care; ePub 2018 Feb 13; van den Boom, et al
These Limb-Specific Factors Predict Amputation, Diabetes Care; ePub 2018 Feb 8; Boyko, et al
Adiposity’s Impact in Mexican-Americans Studied , Obesity; ePub 2018 Feb 10; Black, Shu, Wu, et al
Mortality Is Rising in These People with Diabetes , Diabetes Care; ePub 2018, Feb 7; Kramer, et al
T2D Continuous Care Model Compared to Usual Care, Diabetes Ther; ePub 2018 Feb 7; Hallberg, et al
Must Reads in Lipid Disorders
Cochrane on Statins for Inherited High Cholesterol, Cochrane; 2017 Jul 7; Vuorio, Kuoppala, et al
Impact of Oral Contraceptives, Weight Loss on HDL, LDL, Clin Endocrinol; ePub 2017 Mar 9; Dokras, et al
AACE/ACE Dyslipidemia and Atherosclerosis Guidelines, Endocr Pract; ePub 2017 Feb 3; Jellinger, et al
Triglycerides and Fracture Risk in Midlife Women, J Clin Endocrinol Metab; ePub 2016 Jun 13; Chang, et al
Metabolic Syndrome Components and Polyneuropathy , Diabetes Care; ePub 2016 Mar 10; Callaghan, et al